Lonza Group Ltd ADR LZAGY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $37.47
- Day Range
- $37.06–37.51
- 52-Week Range
- $34.19–66.00
- Bid/Ask
- $34.50 / $38.00
- Market Cap
- $27.77 Bil
- Volume/Avg
- 118,804 / 245,184
Key Statistics
- Price/Earnings (Normalized)
- 24.52
- Price/Sales
- 4.12
- Dividend Yield
- 1.05%
- Dividend Yield (Forward)
- 1.05%
- Total Yield
- 2.26%
Company Profile
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Core
- Total Number of Employees
- 17,896
- Website
- https://www.lonza.com
Competitors
Valuation
|
Metric
|
LZAGY
|
02269
|
ICLR
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.52 | 21.71 | 18.44 |
Price/Book Value | 2.42 | 3.26 | 2.50 |
Price/Sales | 4.12 | 6.86 | 2.81 |
Price/Cash Flow | 16.44 | 17.04 | 19.48 |
Price/Earnings
LZAGY
02269
ICLR
Financial Strength
|
Metric
|
LZAGY
|
02269
|
ICLR
|
|---|---|---|---|
Quick Ratio | 1.36 | 1.79 | 1.14 |
Current Ratio | 2.07 | 2.20 | 1.19 |
Interest Coverage | 18.29 | 40.97 | 2.81 |
Quick Ratio
LZAGY
02269
ICLR
Profitability
|
Metric
|
LZAGY
|
02269
|
ICLR
|
|---|---|---|---|
Return on Assets (Normalized) | 5.83% | 9.91% | 4.01% |
Return on Equity (Normalized) | 9.76% | 14.09% | 7.97% |
Return on Invested Capital (Normalized) | 8.06% | 11.82% | 7.30% |
Return on Assets
LZAGY
02269
ICLR
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Cfmcz | $189.2 Bil | |
DHR
| Danaher Corp | Prhgnb | $160.7 Bil | |
IDXX
| IDEXX Laboratories Inc | Ypcyp | $44.1 Bil | |
IQV
| IQVIA Holdings Inc | Trmzsrq | $39.3 Bil | |
A
| Agilent Technologies Inc | Ftbcb | $37.2 Bil | |
MTD
| Mettler-Toledo International Inc | Zzjzzb | $23.6 Bil | |
ICLR
| Icon PLC | Bjtgt | $22.4 Bil | |
LH
| Laboratory Corp of America Holdings | Skjfvn | $18.4 Bil | |
ILMN
| Illumina Inc | Wdwdpy | $17.9 Bil | |
WAT
| Waters Corp | Rdbm | $17.3 Bil |